EMEA (Europe, Middle East and Africa) Contraceptive Drugs Market Report 2017

October 2017 | 115 pages | ID: E41CB935A3DEN
QYResearch

Abstracts

In this report, the EMEA Contraceptive Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Contraceptive Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Contraceptive Drugs market competition by top manufacturers/players, with Contraceptive Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Cipla
• Bayer
• Merck
• Teva Pharmaceutical
• Allergan
• Pfizer
• Reckitt Benckiser
• Mankind Pharma
• Janssen Pharmaceutical
• HLL Lifecare
• Mithra Pharmaceuticals

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Oral Contraceptives
• Contraceptive Injectable
• Topical Contraceptive Patch

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Contraceptive Drugs for each application, including

• Hospital Pharmacy
• Independent Pharmacy
• Online Platform
• Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Contraceptive Drugs Market Report 2017

1 CONTRACEPTIVE DRUGS OVERVIEW

1.1 Product Overview and Scope of Contraceptive Drugs
1.2 Classification of Contraceptive Drugs
  1.2.1 EMEA Contraceptive Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Contraceptive Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Oral Contraceptives
  1.2.4 Contraceptive Injectable
  1.2.5 Topical Contraceptive Patch
1.3 EMEA Contraceptive Drugs Market by Application/End Users
  1.3.1 EMEA Contraceptive Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital Pharmacy
  1.3.3 Independent Pharmacy
  1.3.4 Online Platform
  1.3.5 Clinics
1.4 EMEA Contraceptive Drugs Market by Region
  1.4.1 EMEA Contraceptive Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Contraceptive Drugs (2012-2022)
  1.5.1 EMEA Contraceptive Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Contraceptive Drugs Revenue and Growth Rate (2012-2022)

2 EMEA CONTRACEPTIVE DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Contraceptive Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Contraceptive Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Contraceptive Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Contraceptive Drugs Sale Price by Players (2012-2017)
2.2 EMEA Contraceptive Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Contraceptive Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Contraceptive Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Contraceptive Drugs Sale Price by Type (2012-2017)
2.3 EMEA Contraceptive Drugs (Volume) by Application
2.4 EMEA Contraceptive Drugs (Volume and Value) by Region
  2.4.1 EMEA Contraceptive Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Contraceptive Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Contraceptive Drugs Sales Price by Region (2012-2017)

3 EUROPE CONTRACEPTIVE DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Contraceptive Drugs Sales and Value (2012-2017)
  3.1.1 Europe Contraceptive Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Contraceptive Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Contraceptive Drugs Sales and Market Share by Type
3.3 Europe Contraceptive Drugs Sales and Market Share by Application
3.4 Europe Contraceptive Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Contraceptive Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Contraceptive Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Contraceptive Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Contraceptive Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Contraceptive Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Contraceptive Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Contraceptive Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Contraceptive Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST CONTRACEPTIVE DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Contraceptive Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Contraceptive Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Contraceptive Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Contraceptive Drugs Sales and Market Share by Type
4.3 Middle East Contraceptive Drugs Sales and Market Share by Application
4.4 Middle East Contraceptive Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Contraceptive Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Contraceptive Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Contraceptive Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Contraceptive Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Contraceptive Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Contraceptive Drugs Sales and Growth Rate (2012-2017)

5 AFRICA CONTRACEPTIVE DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Contraceptive Drugs Sales and Value (2012-2017)
  5.1.1 Africa Contraceptive Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Contraceptive Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Contraceptive Drugs Sales and Market Share by Type
5.3 Africa Contraceptive Drugs Sales and Market Share by Application
5.4 Africa Contraceptive Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Contraceptive Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Contraceptive Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Contraceptive Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Contraceptive Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Contraceptive Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Contraceptive Drugs Sales and Growth Rate (2012-2017)

6 EMEA CONTRACEPTIVE DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Cipla
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Contraceptive Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Cipla Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Contraceptive Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Contraceptive Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Teva Pharmaceutical
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Contraceptive Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Teva Pharmaceutical Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Allergan
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Contraceptive Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Allergan Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pfizer
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Contraceptive Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Reckitt Benckiser
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Contraceptive Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Reckitt Benckiser Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Mankind Pharma
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Contraceptive Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Mankind Pharma Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Janssen Pharmaceutical
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Contraceptive Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Janssen Pharmaceutical Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 HLL Lifecare
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Contraceptive Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 HLL Lifecare Contraceptive Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Mithra Pharmaceuticals

7 CONTRACEPTIVE DRUGS MANUFACTURING COST ANALYSIS

7.1 Contraceptive Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Contraceptive Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Contraceptive Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Contraceptive Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA CONTRACEPTIVE DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Contraceptive Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Contraceptive Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Contraceptive Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Contraceptive Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Contraceptive Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Contraceptive Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Contraceptive Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Contraceptive Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Contraceptive Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Contraceptive Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Contraceptive Drugs
Figure EMEA Contraceptive Drugs Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Contraceptive Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Contraceptives Product Picture
Figure Contraceptive Injectable Product Picture
Figure Topical Contraceptive Patch Product Picture
Figure EMEA Contraceptive Drugs Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Contraceptive Drugs by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Independent Pharmacy Examples
Table Key Downstream Customer in Independent Pharmacy
Figure Online Platform Examples
Table Key Downstream Customer in Online Platform
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure EMEA Contraceptive Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Contraceptive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Contraceptive Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Contraceptive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Contraceptive Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Contraceptive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Contraceptive Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Contraceptive Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Contraceptive Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Contraceptive Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Contraceptive Drugs Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Contraceptive Drugs Sales Share by Players (2012-2017)
Figure 2016 Contraceptive Drugs Sales Share by Players
Figure 2017 Contraceptive Drugs Sales Share by Players
Figure EMEA Contraceptive Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Contraceptive Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Contraceptive Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Contraceptive Drugs Revenue Share by Players
Table 2017 EMEA Contraceptive Drugs Revenue Share by Players
Table EMEA Contraceptive Drugs Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Contraceptive Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Contraceptive Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Contraceptive Drugs by Type (2012-2017)
Figure EMEA Contraceptive Drugs Sales Market Share by Type (2012-2017)
Table EMEA Contraceptive Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Contraceptive Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Contraceptive Drugs by Type in 2016
Table EMEA Contraceptive Drugs Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Contraceptive Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Contraceptive Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Contraceptive Drugs by Application (2012-2017)
Figure EMEA Contraceptive Drugs Sales Market Share by Application in 2016
Table EMEA Contraceptive Drugs Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Contraceptive Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Contraceptive Drugs by Region (2012-2017)
Figure EMEA Contraceptive Drugs Sales Market Share in 2016
Table EMEA Contraceptive Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Contraceptive Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Contraceptive Drugs by Region (2012-2017)
Figure EMEA Contraceptive Drugs Revenue Market Share Regions in 2016
Table EMEA Contraceptive Drugs Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Contraceptive Drugs Revenue and Growth Rate (2012-2017)
Table Europe Contraceptive Drugs Sales (K Units) by Type (2012-2017)
Table Europe Contraceptive Drugs Market Share by Type (2012-2017)
Figure Europe Contraceptive Drugs Market Share by Type in 2016
Table Europe Contraceptive Drugs Sales (K Units) by Application (2012-2017)
Table Europe Contraceptive Drugs Market Share by Application (2012-2017)
Figure Europe Contraceptive Drugs Market Share by Application in 2016
Table Europe Contraceptive Drugs Sales (K Units) by Countries (2012-2017)
Table Europe Contraceptive Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Contraceptive Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Contraceptive Drugs Sales Market Share by Countries in 2016
Table Europe Contraceptive Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Contraceptive Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Contraceptive Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Contraceptive Drugs Revenue Market Share by Countries in 2016
Figure Germany Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure France Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UK Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Contraceptive Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Contraceptive Drugs Sales (K Units) by Type (2012-2017)
Table Middle East Contraceptive Drugs Market Share by Type (2012-2017)
Figure Middle East Contraceptive Drugs Market Share by Type (2012-2017)
Table Middle East Contraceptive Drugs Sales (K Units) by Applications (2012-2017)
Table Middle East Contraceptive Drugs Market Share by Applications (2012-2017)
Figure Middle East Contraceptive Drugs Sales Market Share by Application in 2016
Table Middle East Contraceptive Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Contraceptive Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Contraceptive Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Contraceptive Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Contraceptive Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Contraceptive Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Contraceptive Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Contraceptive Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Contraceptive Drugs Sales (K Units) by Type (2012-2017)
Table Africa Contraceptive Drugs Sales Market Share by Type (2012-2017)
Figure Africa Contraceptive Drugs Sales Market Share by Type (2012-2017)
Figure Africa Contraceptive Drugs Sales Market Share by Type in 2016
Table Africa Contraceptive Drugs Sales (K Units) by Application (2012-2017)
Table Africa Contraceptive Drugs Sales Market Share by Application (2012-2017)
Figure Africa Contraceptive Drugs Sales Market Share by Application (2012-2017)
Table Africa Contraceptive Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Africa Contraceptive Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Contraceptive Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Contraceptive Drugs Sales Market Share by Countries in 2016
Table Africa Contraceptive Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Contraceptive Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Contraceptive Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Contraceptive Drugs Revenue Market Share by Countries in 2016
Figure South Africa Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Cipla Contraceptive Drugs Basic Information List
Table Cipla Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cipla Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Cipla Contraceptive Drugs Sales Market Share in EMEA (2012-2017)
Figure Cipla Contraceptive Drugs Revenue Market Share in EMEA (2012-2017)
Table Bayer Contraceptive Drugs Basic Information List
Table Bayer Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Contraceptive Drugs Sales Market Share in EMEA (2012-2017)
Figure Bayer Contraceptive Drugs Revenue Market Share in EMEA (2012-2017)
Table Merck Contraceptive Drugs Basic Information List
Table Merck Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Contraceptive Drugs Sales Market Share in EMEA (2012-2017)
Figure Merck Contraceptive Drugs Revenue Market Share in EMEA (2012-2017)
Table Teva Pharmaceutical Contraceptive Drugs Basic Information List
Table Teva Pharmaceutical Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Teva Pharmaceutical Contraceptive Drugs Sales Market Share in EMEA (2012-2017)
Figure Teva Pharmaceutical Contraceptive Drugs Revenue Market Share in EMEA (2012-2017)
Table Allergan Contraceptive Drugs Basic Information List
Table Allergan Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Allergan Contraceptive Drugs Sales Market Share in EMEA (2012-2017)
Figure Allergan Contraceptive Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Contraceptive Drugs Basic Information List
Table Pfizer Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Contraceptive Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Contraceptive Drugs Revenue Market Share in EMEA (2012-2017)
Table Reckitt Benckiser Contraceptive Drugs Basic Information List
Table Reckitt Benckiser Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Reckitt Benckiser Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Reckitt Benckiser Contraceptive Drugs Sales Market Share in EMEA (2012-2017)
Figure Reckitt Benckiser Contraceptive Drugs Revenue Market Share in EMEA (2012-2017)
Table Mankind Pharma Contraceptive Drugs Basic Information List
Table Mankind Pharma Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mankind Pharma Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Mankind Pharma Contraceptive Drugs Sales Market Share in EMEA (2012-2017)
Figure Mankind Pharma Contraceptive Drugs Revenue Market Share in EMEA (2012-2017)
Table Janssen Pharmaceutical Contraceptive Drugs Basic Information List
Table Janssen Pharmaceutical Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Pharmaceutical Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Janssen Pharmaceutical Contraceptive Drugs Sales Market Share in EMEA (2012-2017)
Figure Janssen Pharmaceutical Contraceptive Drugs Revenue Market Share in EMEA (2012-2017)
Table HLL Lifecare Contraceptive Drugs Basic Information List
Table HLL Lifecare Contraceptive Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure HLL Lifecare Contraceptive Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure HLL Lifecare Contraceptive Drugs Sales Market Share in EMEA (2012-2017)
Figure HLL Lifecare Contraceptive Drugs Revenue Market Share in EMEA (2012-2017)
Table Mithra Pharmaceuticals Contraceptive Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Contraceptive Drugs
Figure Manufacturing Process Analysis of Contraceptive Drugs
Figure Contraceptive Drugs Industrial Chain Analysis
Table Raw Materials Sources of Contraceptive Drugs Major Manufacturers in 2016
Table Major Buyers of Contraceptive Drugs
Table Distributors/Traders List
Figure EMEA Contraceptive Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Contraceptive Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Contraceptive Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Contraceptive Drugs Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Contraceptive Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Contraceptive Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Contraceptive Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Contraceptive Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Contraceptive Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Contraceptive Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Contraceptive Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Contraceptive Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Contraceptive Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Contraceptive Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Contraceptive Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Contraceptive Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Contraceptive Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Contraceptive Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Contraceptive Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Contraceptive Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Contraceptive Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Contraceptive Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Contraceptive Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources